Intramuscular (im) or intradermal (i.d.) injection of mice
ery necessary for establishing a retroviral infection in with ''naked'' plasmid DNA expression vectors encoding vivo have been reported (Letvin et al., 1991; Portis et al. , a specific immunogen results in protein expression and 1992; Willems et al., 1992) . induction of long-lasting cellular and humoral immune For this report, we compared infectivity in cats of feline responses (Wolff et al., 1990 (Wolff et al., , 1992 Tang et al., 1992;  immunodeficiency virus (FIV) cloned proviral DNA with Ulmer et al., 1993; Raz et al., 1994; Donnelly et al., 1995;  virus grown in tissue culture cells. The plasmid encoding Huygen et al., 1996; Kumar and Sercarz, 1996) . Inoculathe PPR molecular clone of FIV (FIV-pPPR) has been tion of the host with plasmid or bacteriophage l vectors determined infectious by transfection of adherent feline containing an infectious retroviral DNA genome also procell lines and cocultivation with feline peripheral blood duces virus expression and infection (Letvin et al., 1991; mononuclear cells (PBMC) . Live virus recovered from this Portis et al., 1992; Willems et al., 1992 Willems et al., , 1993 . Advantages clone establishes a persistent viremia, detected by virus of using proviral DNA inoculation over live virus preparaisolation and seroconversion in cats (Phillips et al., tions for both pathogenesis and attenuated viral vaccine 1990; Sparger et al., 1994) . Based on data presented studies include relative stability and ease of standardizabelow, im inoculation of cats with 100 to 300 mg of infection of plasmid DNA inocula. Sequence changes retious FIV-pPPR proviral DNA induced a viremia very simisulting from passage of viral clones in cell culture can lar in kinetics to that observed with a live virus preparabe obviated by direct viral DNA injection. In addition, tion of FIV. plasmid vectors encoding a bacterial ampicillin resisSupercoiled plasmid DNA for inoculation studies was tance gene contain short immunostimulatory DNA seprepared by a standard alkaline lysis protocol and puriquences (ISS) which may augment immune responses, fied by centrifugation to equilibrium twice in cesium chlowith a T helper cell type 1 (T H 1) bias, to viral antigens ride-ethidium bromide gradients (Sambrook et al., 1989) . expressed from the provirus encoded in the plasmid Plasmid DNA, in concentrations described below, was (Sato et al., 1996) . However, relatively few studies evaluresuspended in 1 ml of sterile physiological saline for ating proviral DNA concentration and mode of DNA delivinoculation by hypodermic syringe (22 gauge) in the rear limb quadriceps muscle. The FIV-pPPR virus stock was generated by transfec- Note. For virus isolations, (/) indicates PBMC (2 1 10 6 ) cultures were positive for FIV p24 Gag by day 28 in culture. For time points 12 and 15 weeks p.i., virus isolations were performed on serial dilutions of 10 6 PBMC and the lowest concentrations of PBMC producing FIV p24 Gag are noted. Serum antibody titer to FIV p24 Gag was assayed by an ELISA based on recombinant FIV Gag protein [George, 1993, 36] and expressed as the reciprocal of the highest dilution of serum positive for antibody. Sera with an antibody titer of less than 1:100 are noted as negative (0). cells) (Sparger et al., 1992) with an infectious FIV-pPPR or live virus, PBMC were isolated from peripheral blood by density gradient centrifugation in Ficoll/Hypaque (Hisprovirus construct (pSV-pPPR) encoding a hybrid 5 LTR composed of the SV40 early enhancer region and TATA topaque; Sigma, St. Louis, MO). PBMC (2 1 10 6 ) were cultured in 6-well plates for 28 days using conditions box, a deleted U3 (bp 01 to 010), and full-length R and U5 (L. Bigornia, H. Louie, and E. E. Sparger, manuscript previously described (Sparger et al., 1994) , and cell culture supernatants were assayed twice a week for viral in preparation). Virus stock was prepared by short-term passage in feline PBMC.
antigen by a capture ELISA for FIV capsid protein p24 (Dandekar et al., 1992) . At later time points (12 and 15 To determine the minimum dose of FIV-pPPR plasmid DNA necessary to achieve viral infection by IM inoculaweeks) p.i. with proviral DNA, and all time points p.i. with live virus preparations, 10-fold serial dilutions of 10 6 tion, groups of specific pathogen-free (SPF) cats were inoculated with different concentrations of plasmid DNA PBMC were cultured in 24-well plates and monitored for virus production for 28 days for semiquantitative virus containing FIV-pPPR proviral DNA. Juvenile SPF cats (7-9 months in age) were obtained from the SPF cat colony isolation. Serum was obtained every 2 weeks from cats in each of Dr. J. G. Morris and Dr. Q. R. Rogers (University of California, Davis) and housed in pathogen-free quarters group up to 15-16 weeks postinoculation and titered for antibody against FIV p24 Gag with an ELISA using of the Animal Resources Services (University of California, Davis). Group I cats each received a single dose of recombinant FIV p24 (George et al., 1993) . Sera found positive by ELISA at dilutions of 1:100 or greater were 300 mg of FIV-pPPR plasmid DNA by im injection; group II cats received a single im injection of 100 mg of FIVconsidered antibody positive and were confirmed by immunoblot analysis with whole virus as previously depPPR, and group III cats received a single im injection of 30 mg (Table 1) . Each of the group IV cats was inocuscribed (Yamamoto et al., 1988) . Virus was first detected 4 weeks p.i. in cats inoculated lated by the i.d. route with 30 mg of FIV-pPPR plasmid DNA (Table 1) . Except for one cat (group II) which diswith FIV-pPPR plasmid DNA (Table 1) , whereas viremia was detected as early as 2 weeks p.i. in three of five played a transient fever 3 hr postinoculation (p.i.) no side effects were observed in cats as a result of either im or cats inoculated with the live virus preparation of FIVpPPR (Table 2 ). Virus was detected by 4 weeks p.i. in all i.d. injection of plasmid proviral DNA. A separate group of five cats (group V) was inoculated by the ip route with three cats inoculated im with 300 mg FIV-pPPR, in two of three cats inoculated im with 100 mg, and in four of 10 3 TCID 50 of FIV-pPPR virus stock prepared from SPF feline PBMC (Table 2) .
five cats inoculated with live virus preparations. By 8 weeks p.i., all three cats injected im with 100 mg and two To assess viremia postinjection of either proviral DNA Note. For virus isolations, (0) indicates PBMC cultures remained negative for FIV p24 Gag whereas a number value represents the lowest concentration of cells from which virus could be isolated by day 28 in culture. Serum antibody titer to FIV p24 Gag was assayed by an ELISA based on recombinant FIV Gag protein [George, 1993, 36] and expressed as the reciprocal of the highest dilution of serum positive for antibody. Sera with an antibody titer of less than 1:100 are noted as negative (0). of three cats inoculated im with 30 mg of FIV-pPPR were whereas titers of live retrovirus preparations, determined by end-point dilution, are not precise. Due to the ease viremic (Table 1) . Intradermal inoculation of 30 mg of FIVpPPR resulted in viremia (by 8 weeks) in only one of and economy of DNA purification, inoculation of plasmids encoding infectious proviruses provides an efficient three cats. Although virus was not detected at 8 weeks p.i. in cats inoculated with 300 mg of proviral DNA, all mode of delivery of attenuated retrovirus vaccines. DNA inoculation will facilitate the assessment of immunostimthree of these animals were once again virus positive at 12 and 15 weeks p.i.. ulatory DNA sequences which can be introduced into the plasmid vector or into the viral genome (Sato et al., The kinetics of seroconversion and viral antibody titer were similar for cats inoculated with 300 or 100 mg of 1996). Also from a vaccine standpoint, inoculation of animals with proviral plasmids is a means to obviate prob-FIV-pPPR plasmid DNA or with the live virus preparation of FIV-pPPR; viral antibody was detected in these groups lems of stability of live attenuated viruses during in vitro passage through cell cultures. by 6-8 weeks p.i. (Tables 1 and 2 ). In contrast, viral antibody was not detected until 10-12 weeks p.i. in viremic cats inoculated either im or i.d. with 30 mg of FIV-ACKNOWLEDGMENTS pPPR plasmid DNA (Table 1 ). All seropositive cats were cats with 100 mg of FIV-pPPR plasmid DNA is sufficient to induce FIV infection with viremia kinetics either similar REFERENCES to or slightly delayed when compared to inoculation with
